| Literature DB >> 36157611 |
Fahd Khefacha1, Wissem Triki1, Karim Ayed1, Imed Abbassi1, Abdelmajid Baccar1, Oussema Baraket1, Sami Bouchoucha1.
Abstract
Clear cell carcinoma (CCC) is usually seen in tissues originating from the paramesonephric (Müllerian) ducts such as the kidneys, the ovaries, the cervix and the vagina. The pathogenesis has not yet been elucidated. The diagnostic hallmark is the clear cytoplasm. Primitive CCC of the colon is a very rare entity. There are two types of CCC of the colon; the intestinal type and the Müllerien type. The differential diagnosis arises mainly with secondary metastases of renal or ovarian origin. Immunohistochemistry allows retaining the primitive character. The treatment is not yet consensual. It depends on the type of tumor and its stage. The treatment is based on surgery and possibly chemotherapy. We report the case of a 75-year-old female patient who underwent surgery for a tumor of the ascending colon. Microscopic examination concluded an extensively necrotic carcinomatous growth which infiltrated all the layers of the intestinal wall and the peritoneum. The tumor was made of clusters and spans of clear cells which were separated by thin conjunctivo-vascular septa. The tumor cells were round to polygonal with a clear, optically empty, pseudo-vegetative (physaliferous) cytoplasm. Immunohistochemistry study showed a positive staining with CK7 and a negative staining with CK20, CDX2, PAX8, P63, CD10, chromogranin, and synaptophysin. We performed a Medical Literature databases (Pubmed and Google Scholar) research. Only forty-two cases were reported in English literature. The main age is 55.7 (25-89). The sex ratio is one, but female cases were younger (52 vs. 61). The rectum is the most involved site. The left colon location is more frequent than the right one. The Müllerian type was found only at the level of the left colon and rectum. There was no CCC in the right colon of Müllerien type. The case we report herein is the first right colon CCC which is positive in CK7 staining.Entities:
Keywords: Clear cell carcinoma; Colon cancer; Colorectal carcinoma; Endometriosis; Intestinal neoplasm; Molecular analysis
Year: 2022 PMID: 36157611 PMCID: PMC9459579 DOI: 10.1159/000525071
Source DB: PubMed Journal: Case Rep Gastroenterol ISSN: 1662-0631
Fig. 1Gross examination of the surgical specimen showing an 8 cm, circumferential tumor (arrow) which was highly necrotic.
Fig. 2Microscopic examination (×4 objective) showing clusters and spans of clear cells, separated by thin conjunctivo-vascular septa.
Fig. 3Microscopic examination (×10 objective) showing the tumor cells, which were round to polygonal with a clear, optically empty, pseudo-vegetative (physaliferous) cytoplasm.
Fig. 4Immunohistochemistry study (×10 objective) showing an intense and diffuse staining of tumor cells with CK7.
Main characteristics of patients, tumor site, size, and TNM state
| Authors | Age | Sex | Tumor site | Size (cm) | T | N | M |
|---|---|---|---|---|---|---|---|
| Hellestrom and Fisher [ | 67 | M | Rectum | 2 | NM |
| 0 |
| Reed et al. [ | 71 | M | Transverse colon | 7 | NM | NM | NM |
| Jewell et al. [ | 75 | M | Rectum | 2 | NM | 0 | 0 |
| 56 | F | Left colon | 6 | NM | 0 | 0 | |
| Watson [ | 53 | M | Anal canal | 3.5 | NM |
| 0 |
| Hitti et al. [ | 39 | F | Sigmoid | 6.5 | NM | 0 | 0 |
| Young and Hart [ | 27 | F | Small intestine | NM | 4 |
| 1 |
| 33 | F | Transverse colon | NM | NM | NM | NM | |
| 33 | F | Left colon | NM | NM | NM | NM | |
| 49 | F | NM | NM | NM | NM | NM | |
| 71 | F | NM | NM | NM | NM | NM | |
| Rubio [ | 68 | M | Left colon | 6 | 4 | 2 | 1 |
| Sasaki et al. [ | 49 | F | Rectum | NM | NM | NM | NM |
| McCluggage et al. [ | 65 | F | Rectum | NM | 3 | NM | 1 |
| Mallikand Katchy [ | 36 | F | Rectum | 5 | 3 | 1 | 0 |
| Braumann et al. [ | 89 | M | Left colon | 2.2 | 2 | 0 | 0 |
| Ko et al. [ | 62 | M | Left colon | 1.5 | In situ | 0 | 0 |
| Hao et al. [ | 37 | M | Rectum | NM | 3 |
| NM |
| Sawai [ | 56 | F | Rectum | NM | NM | NM | NM |
| Houma 2007 [ | 50 | F | Rectum | NM | NM | NM | NM |
| Eloy et al. [ | 48 | F | Transverse colon | 2.5 | In situ | 0 | 0 |
| Soga et al. [ | 71 | F | Right colon | NM | In situ | 0 | 0 |
| Barisella et al. [ | 54 | M | Right colon | 0.9 | 2 | 0 | 0 |
| Bressenot et al. [ | 84 | F | Left colon | 3.5 | 4 | 0 | 0 |
| Finkelstein et al. [ | 41 | F | Rectum | 5 | 2 | 0 | 0 |
| Shi et al. [ | 52 | M | Rectum | 0.9 | 1 | NM | NM |
| 51 | M | Sigmoid | 1.4 | 1 | 0 | 0 | |
| Furuya et al. [ | 81 | M | Right colon | 10 | 3 | 2 | 1 |
| Bakshi et al. [ | 42 | M | Right colon | 4 | 3 | 0 | 0 |
| Kanstrup et al. [ | 69 | M | Sigmoid | NM | 3 | 0 | 0 |
| Barrera-Maldonado et al. [ | 41 | F | Left colon | NM | 2 | 1 | 0 |
| Min et al. [ | 50 | F | Rectum | 2.5 | 2 | 0 | 0 |
| Gurzu et al. [ | 82 | M | Rectum | 5 | 4 | 2 | 1 |
| Wang et al. [ | 26 | M | Left colon | 13 | 4 | NM | 1 |
| Okazawa et al. [ | 83 | F | Rectum | 4 | 4 | 0 | 0 |
| Thelin et al. [ | 25 | M | Right colon | 3 | NM | NM | NM |
| Remo et al. [ | 58 | M | Right colon | 7 | 4 | 2 | 0 |
| 79 | M | Right colon | 4.5 | 4 | 0 | 0 | |
| Tochio et al. [ | 48 | M | Left colon | 2.5 | NM | NM | NM |
| Oyama et al. [ | 58 | M | Sigmoid | 2.5 | 1 | NM | NM |
| Current case | 75 | F | Right colon | 8 | 4 | 0 | 0 |
M, male; F, female; NM, not mentioned.
Staining characteristics and type of CCC cases
| Authors | Coloration (positivity) | Immunohistochemistry (positivity) | Associated lesion | Type (intestinal/Müllerien) |
|---|---|---|---|---|
| Hellestrom and Fisher [ | PAS, D-PAS, Alcian blue | |||
| Jewell et al. [ | CEA, EMA, low-molecular weight keratin | Intestinal | ||
| CEA, EMA, low-molecular weight keratin | Intestinal | |||
| Watson [ | PAS | CEA, EMA, low-molecular weight keratin | Adenoma | Intestinal |
| Hitti et al. [ | Endometriosis | Müllerien | ||
| Rubio [ | PAS | CEA, TPA | − | |
| Sasaki et al. [ | Endometriosis | Müllerien | ||
| Young and Hart [ | Crohn's disease Crohn's disease | |||
| McCluggage et al. [ | PAS, laminin type IV collagen | CA125, CK7, Ber-EP4 | Endometriosis | Müllerien |
| Braumann et al. [ | CEA, EMA, CK18, CK20 | Hyperplastic polyps | Intestinal | |
| Mallik and Katchy [ | PAS, Alcian Blue | CEA, EMA | − | |
| Ko et al. [ | Adenoma | |||
| Hao et al. [ | PAS | CEA, EMA | ||
| Swai [ | CK7 | Endometriosis | Müllerien | |
| Houma [ | CK7 | Endometriosis | Müllerien | |
| Soga et al. [ | PAS | CD10, CK20, p53, Ki67 | Adenoma | Intestinal |
| Barisella et al. [ | CEA, CK20, p53, hMLH1, hMSH2, B-catenin | Adenoma | Intestinal | |
| Bressenot et al. [ | CEA, CK20, Ki67 | − | Intestinal | |
| Eloy et al. [ | CK20, CDX2, CEA, p53 | Adenoma | Intestinal | |
| Finkelstein et al. [ | CK7, p53, ER, PR, CD10 | Endometriosis | Müllerien | |
| Shi et al. [ | CK20, CDX2 | Adenoma | Intestinal | |
| CK20, CDX2 | Adenoma | Intestinal | ||
| Furuya et al. [ | PAS, D-PAS | CEA, EMA, CK AE1/3, CK20, c-kit, B-catenin | Intestinal | |
| Kanstrup et al. [ | Adenoma | |||
| Min et al. [ | CK7, ER, CD10 | Endometriosis | Müllerien | |
| Barrera-Maldonado et al. [ | CK20, CK10, CDX2, villin | Intestinal | ||
| Gurzu et al. [ | AE1/AE3, CK20, CK7, EMA, CEA, CD10, maspin | |||
| Wang et al. [ | Cytokeratin, EMA | |||
| Okazawa et al. [ | CK7, ER | Endometriosis | Müllerien | |
| Remo et al. [ | CK20, CEA, MUC2, CDX-2 | Intestinal | ||
| CK20, CEA, MUC2, CDX-2, E-cadherin, p53 | Prostate carcinoma | Intestinal | ||
| Tochio et al. [ | CK20, CDX-2, MUC2, CEA, Ki67, p53, B-catenin | Adenoma | Intestinal | |
| Oyama et al. [ | CK20, CDX2, MUC2, CEA, CD10, C0X2, APC, Ki67 | Adenoma | Intestinal | |
| Current case | CK7 | Müllerien |
CK, cytokeratin; CDX2, caudal type homeobox 2; CEA, carcinoembryonic antigen; CD, cluster differentiation; MUC, mucin; C0X2, cyclooxygenase 2; APC, adenomatous polyposis coli; PAS, periodic acid-Schiff; D-PAS, periodic acid-Schiff with diastase treatment; EMA, epithelial membrane antigen; TPA, tissue polypeptide antigen; p53, p53 protein; Ki67, Ki67 labeling index.